Cat: IPD-X39025

Recombinant Mouse CRYbA1 Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • Gene name

    CRYbA1

  • Application

    SPRMSTBLIITCELISACELL ASSAYDRUG SCREENING

  • Alternative Names

    CRYB1; Eye Lens Structural Protein

  • Species

    Mouse

  • Source

    E. coli

  • Tag

    N-His

  • Purity

    Greater than 90% as determined by SDS-PAGE.

  • Uniprot

    P02525

  • Expression Region

    Met1~Gln215

  • Molecular Weight

    29kDa

  • Endotoxin

    < 1.0 EU per μg protein as determined by the LAL method.

  • Form

    Freeze-dried powder

  • Buffer formulation

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • Reconstitution

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • Customization

    Site-directed mutagenesis Custom tag design Custom buffer formulation Custom full-length protein production

  • Stability Test

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • Storage & Shelf Life

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • Shipping

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

CRYbA1 is a unique photoreceptor protein that belongs to the cryptochrome family, which plays a crucial role in the regulation of circadian rhythms and various physiological processes. Originating from specific plant and animal species, research on CRYbA1 has gained significant attention due to its potential applications in understanding light signaling pathways and their impact on biological functions. Recent advancements in molecular biology techniques have enabled scientists to express and purify CRYbA1 as a recombinant protein, facilitating in-depth studies of its structure and function. Investigations have revealed the interaction of CRYbA1 with other cellular components and its role in modulating gene expression in response to light stimuli. The ability to produce large quantities of CRYbA1 in a laboratory setting enhances the potential for biochemical assays, structural biology studies, and drug discovery efforts targeting circadian rhythm-related disorders. Moreover, elucidating the mechanisms by which CRYbA1 functions could contribute to the development of novel strategies for improving crop yields and resilience in plants. As a result, CRYbA1 recombinant protein studies are not only pivotal for fundamental research but also hold significant promise for practical applications in agriculture and medicine. The ongoing exploration of CRYbA1 highlights the intricate relationship between light and biological systems, underscoring the importance of this protein in advancing our understanding of circadian biology and its relevance to health and sustainability.

E-mail

sales@ipodix.com

Sales

+1 2092920560


Contact us via WhatsApp

IPODIX Biotech Inc

2108 N ST, STE N
Sacramento, CA 95816, USA

For Product Information and Orders

sales@ipodix.com

For Business Collaboration

sales@ipodix.com

For CRO Services

sales@ipodix.com

For Technical Support

sales@ipodix.com
  • 50000+

    Recombinant Proteins

  • 100+

    Researchers

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US